Vectura is an industry-leading device & formulation business for inhaled airways disease.
Horizon Discovery is a world-leader in the application of gene editing and gene modulation technologies and is at the centre of innovation and drug discovery.
IBA is a global leader in proton therapy solutions for the treatment of cancer.
Arix Bioscience is focused on generating value from innovation in healthcare, with a permanent capital structure supporting a long-term investment model.
Immunocore is a leading T cell receptor (TCR) company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, through its pioneering soluble TCR technology platform.
Quanta is a medical device company providing innovative haemodialysis solutions for the clinic and the home.